Search research articles
Contact Us
Filters
Showing results (1-10 of 95) with videos related to
Page
of 10
Sort By:
Thrombosis Research
|
March 26, 2005
Bleeding disorders in neonates
G Kenet
Journal of Thrombosis and Haemostasis : JTH
|
May 14, 2004
Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors
T Abshire, G Kenet
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 16, 2002
The impact of chronic disease on the family
G Goldstein, G Kenet
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 1, 2008
Applicability and safety of recombinant activated factor VII to control non-haemophilic haemorrhage: investigational experience in 265 children
M Herbertson, G Kenet
Harefuah
|
May 2, 1993
[Autologous cord blood transfusion]
A Balin, G Kenet
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 8, 2008
Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors
T Abshire, G Kenet
Blood Cells, Molecules & Diseases
|
November 9, 2017
Editorial for special pediatric hemostasis issue BCMD
G Kenet, U Nowak-Göttl
Seminars in Fetal & Neonatal Medicine
|
September 6, 2011
Thrombotic and bleeding disorders in perinatal medicine
G Kenet, U Nowak Gottl
Journal of Thrombosis and Haemostasis : JTH
|
March 10, 2012
Developmental hemostasis: recommendations for laboratories reporting pediatric samples
V Ignjatovic, G Kenet, P Monagle, et al.
Seminars in Fetal & Neonatal Medicine
|
August 4, 2011
Developmental hemostasis: primary hemostasis and evaluation of platelet function in neonates
T Strauss, R Sidlik-Muskatel, G Kenet
Page
of 10
Search research articles
Search
Showing results (1-10 of 95) with videos related to
Sort By:
Page
of 10
Thrombosis Research
|
March 26, 2005
Bleeding disorders in neonates
G Kenet
Journal of Thrombosis and Haemostasis : JTH
|
May 14, 2004
Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors
T Abshire, G Kenet
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 16, 2002
The impact of chronic disease on the family
G Goldstein, G Kenet
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
May 1, 2008
Applicability and safety of recombinant activated factor VII to control non-haemophilic haemorrhage: investigational experience in 265 children
M Herbertson, G Kenet
Harefuah
|
May 2, 1993
[Autologous cord blood transfusion]
A Balin, G Kenet
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
August 8, 2008
Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors
T Abshire, G Kenet
Blood Cells, Molecules & Diseases
|
November 9, 2017
Editorial for special pediatric hemostasis issue BCMD
G Kenet, U Nowak-Göttl
Seminars in Fetal & Neonatal Medicine
|
September 6, 2011
Thrombotic and bleeding disorders in perinatal medicine
G Kenet, U Nowak Gottl
Journal of Thrombosis and Haemostasis : JTH
|
March 10, 2012
Developmental hemostasis: recommendations for laboratories reporting pediatric samples
V Ignjatovic, G Kenet, P Monagle, et al.
Seminars in Fetal & Neonatal Medicine
|
August 4, 2011
Developmental hemostasis: primary hemostasis and evaluation of platelet function in neonates
T Strauss, R Sidlik-Muskatel, G Kenet
Page
of 10